"Designing Growth Strategies is in our DNA"

Hepatitis C Testing Market Size, Share and Global Trend, By Technique ( Immunoassays, Polymerase Chain Reaction ( PCR ), Others), By Test ( Antibody Test, Genotype Tests, Viral Load Test), By End User ( Hospital-based Laboratories, Stand-alone Laboratories, Others), and Geography Forecast till 2026

Region : | Report ID: FBI100461 | Status : Ongoing

 

KEY MARKET INSIGHTS

Hepatitis C is a liver disease caused by the hepatitis C virus. There are mainly three types of hepatitis found namely hepatitis A, B, and C. Each is caused by different viruses. Hepatitis C is caused by the hepatitis C virus (HCV) which is commonly prevalent over the other 2 forms of hepatitis. Hepatitis C is transmitted through direct contact with infected body fluids, majorly through injection, drugs use and sexual contact. Recently, in 2013, OraSure Technologies, Inc., launched OraQuick HCV antibody mouth swab test, which produces results in 20 minutes.


Rising prevalence of liver cancer, improving diagnosis rates for hepatitis C virus in emerging countries, and increasing number of government programs spreading awareness regarding hepatitis C testing are some of the major factors driving the growth of the global hepatitis C testing market. Hepatitis C test has been made mandatory for the organ donation, this is a major driver for the global hepatitis C testing market.


To gain extensive insights into the market, Request for Customization


Inadequate insurance and reimbursement policies for hepatitis C testing market and lack of awareness about the rapid hepatitis C testing in developing countries are some of the factors restraining the growth of the global hepatitis C testing market during the forecast period of 2019-2026.


Key Players Covered


Some of the major companies that are present in the global Hepatitis C Testing market are OraSure Technologies, Inc., Abbott, Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Bayer AG, QIAGEN, Thermo Fisher Scientific Inc., BioGenex, AccuQuick, and others.


Segmentation


























Segmentation



 Details



By Technique



·         Immunoassays


·         Polymerase Chain Reaction (PCR)


·         Others



By Test



·         Antibody Test


·         Genotype Tests


·         Viral Load Test



By End User



·         Hospital-based Laboratories


·         Stand-alone Laboratories


·         Others



By Geography



·         North America (USA and Canada)


·         Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


·         Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


·         Latin America (Brazil, Mexico and Rest of Latin America)


·         Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



In 2018, Hepatitis C antibody test accounted for the highest share of the test segment in the global hepatitis C testing market due to increased demand and better clinical efficiency. The segment is projected to continue its dominance in the market share during the forecast period.



 Key Insights


Pricing Analysis by Key Regions


Reimbursement Scenario for Key Countries


Recent industry developments such as partnerships, mergers, and acquisitions


Regional Analysis


The global hepatitis C testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for Hepatitis C testing in 2018. North America accounted for the largest share of the global hepatitis C testing market in 2018, owing to the increasing prevalence of hepatitis C. Asia-Pacific and Latin America are anticipated to grow at a comparatively higher CAGR during the forecast period, owing to the growing awareness of advanced products for hepatitis C testing in emerging countries, the increasing patient population suffering from hepatitis C.


Key Industry Developments     



  • In April 2019, Access Bio Inc. and Atomo Diagnostics announced the development of the rapid diagnostic test (RDT) for screening for hepatitis C virus (HCV). It is expected that the tests will be made commercially available by end of this year.

  • In March 2019, Gilead Sciences, Inc., announced the HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia.

  • In September 2018, London Drugs took initiative towards the innovative and potentially life-saving hepatitis C screening program which is been launched at five London Drugs locations in the Lower Mainland.


 


Hepatitis C Testing Market  Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Healthcare Clients

baxter
Logo_Merck_KGaA_2015
SUANFARMA
Intuitive_Surgical_logo
DAEWOONG

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X